Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice

J Virol. 2019 May 15;93(11):e02123-18. doi: 10.1128/JVI.02123-18. Print 2019 Jun 1.

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection is associated with aberrant immune activation; however, most model systems for HIV-1 have been used during established infection. Here, we utilize ultrasensitive HIV-1 quantification to delineate early events during the eclipse, burst, and chronic phases of HIV-1 infection in humanized mice. We show that very early in infection, HIV-1 suppresses peripheral type I interferon (IFN) and interferon-stimulated gene (ISG) responses, including the HIV-1 restriction factor IFI44. At the peak of innate immune activation, prior to CD4 T cell loss, HIV-1 infection differentially affects peripheral and lymphoid Toll-like receptor (TLR) expression profiles in T cells and macrophages. This results in a trend toward an altered activation of nuclear factor κB (NF-κB), TANK-binding kinase 1 (TBK1), and interferon regulatory factor 3 (IRF3). The subsequent type I and III IFN responses result in preferential induction of peripheral ISG responses. Following this initial innate immune activation, peripheral expression of the HIV-1 restriction factor SAM domain- and HD domain-containing protein 1 (SAMHD1) returns to levels below those observed in uninfected mice, suggesting that HIV-1 interferes with their basal expression. However, peripheral cells still retain their responsiveness to exogenous type I IFN, whereas splenic cells show a reduction in select ISGs in response to IFN. This demonstrates the highly dynamic nature of very early HIV-1 infection and suggests that blocks to the induction of HIV-1 restriction factors contribute to the establishment of viral persistence.IMPORTANCE Human immunodeficiency virus type 1 (HIV-1) infection is restricted to humans and some nonhuman primates (e.g., chimpanzee and gorilla). Alternative model systems based on simian immunodeficiency virus (SIV) infection of macaques are available but do not recapitulate all aspects of HIV-1 infection and disease. Humanized mice, which contain a human immune system, can be used to study HIV-1, but only limited information on early events and immune responses is available to date. Here, we describe very early immune responses to HIV-1 and demonstrate a suppression of cell-intrinsic innate immunity. Furthermore, we show that HIV-1 infection interacts differently with innate immune responses in blood and lymphoid organs.

Keywords: human immunodeficiency virus; humanized mouse; innate immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • Dendritic Cells / immunology
  • HEK293 Cells
  • HIV Infections / immunology*
  • HIV Infections / metabolism*
  • HIV-1 / immunology
  • HIV-1 / metabolism
  • Humans
  • Immunity, Innate / physiology*
  • Interferon Regulatory Factor-3 / metabolism
  • Interferon Type I / immunology
  • Interferon Type I / metabolism
  • Kinetics
  • Macrophages / virology
  • Mice
  • NF-kappa B / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • SAM Domain and HD Domain-Containing Protein 1 / metabolism

Substances

  • IRF3 protein, human
  • Interferon Regulatory Factor-3
  • Interferon Type I
  • NF-kappa B
  • Protein Serine-Threonine Kinases
  • TBK1 protein, human
  • SAM Domain and HD Domain-Containing Protein 1
  • SAMHD1 protein, human